The automated external defibrillator market is estimated to reach USD 1,330.3 million in 2024. It is estimated that revenue will increase at a CAGR of 4.7% between 2024 and 2034. The market is anticipated to reach USD 2,097.1 million by 2034.
An automated external defibrillator is a medical device which is used to revive people experiencing sudden cardiac arrest (SCA). It is a sophisticated medical device that has ability to analyze the heart rhythm and deliver electric shock. Increase in number of people facing sudden cardiac arrest owing to the sedentary lifestyle, majorly contributes to the growth of the market.
In addition, growing emphasis of manufacturers on launch of new product to the market with an aim of expansion of their product portfolio, along with their increased focus towards inclusion of instructions that are easily understood by a layperson during an emergency situation further anticipates the growth of the market.
Automated External Defibrillator Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 1,269.1 million |
| Estimated Size, 2024 | USD 1,330.3 million |
| Projected Size, 2034 | USD 2,097.1 million |
| Value-based CAGR (2024 to 2034) | 4.7% |
An automated external defibrillator (AED) is a portable device that can automatically detect abnormal heart rhythms and deliver an electric shock for re-establishment of a normal heartbeat. AEDs have been designed for emergency use-specifically, in sudden cardiac arrest cases.
The device is designed for laypersons of which can be used with minimal training to survive a patient until help from a trained medical professional arrives.
The market has witnessed increased demand for AEDs owing to the rising number of people suffering from sudden cardiac arrest in ageing population and increase in number of young people following sedentary lifestyle.
For instance, according to the statistics published by Sudden Cardiac Arrest Foundation in 2022, more than 356,000 out-of-hospital cardiac arrests (OHCA) occur annually in the United States, among which nearly 90% of them fatal.
To combat this rising prevalence of sudden cardiac arrest cases and increase the survival rate of the patient witnessing SCA government of the developed and developing economies has amended several laws for the implementation of AEDs in public areas.
Following to this amended laws and regulations, many of the non-profit organizations in collaboration with manufacturers has initiated several public awareness campaigns for raising awareness of sudden cardiac arrest among society.
For instance, in June 2023, The American Heart Association collaborated with Lexington Fire Department and launched #LEXSaveLives campaign. Under this campaign they’ll be equipping Lexington’s 24 fire stations with new CPR manikin and educate and raise awareness on the use of AED.
With an aim to meet this growing demand and stay competitive and ahead of the market many of the manufacturers are emphasizing on launch of new products to the market that has an inclusion of enhanced features such as voice guided instructions, improved shock delivery mechanism and real time CPR feedback. For instance, in March 2024, Stryker launched next gen LIFEPAK CR2 AED for cardiac care” and “Evacuation Chair” for emergency patient evacuation.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Emphasis of Manufacturers on Launch of New Products to the Market Surges the Market Growth
The evolving needs of healthcare facilities encourage manufacturers to prioritize the development and innovation of a user-friendly AED devices that has ability to cater broader range of medical settings which has an inclusion of hospitals, clinics, and public spaces. This demand encourages manufacturers to develop products that are lightweight and portable.
Moreover, in addition to stay ahead in the competition they are including several advanced features in their products such as wireless connectivity that also allows remote monitoring ensuring device readiness. Inclusion of these systems not only improve the efficacy and accessibility of AEDs but also expands their applications in several public settings such as schools, public spaces, and workplaces.
For instance, in January 2023, Avive Solutions, Inc., received United States FDA pre-market approval (PMA) for its Avive AED, a unique Automated External Defibrillator (AED) which is designed for easy placements in variety of locations.
This emphasis of manufacturers on launch of new products aid them to diversify their products by addressing several specific needs. This factor also enables them to stay competitive, assist them to maintain their pace with the regulatory standards and meet the ever increasing expectations of the customers.
Thus, the growing emphasis of manufacturers on introduction of new, technologically advanced AEDs aid them to expand their market penetration and strengthen their presence in the market.
Growing Emphasis of Regulatory Authorities on Introduction of Public Access Bills for AEDs Surges Growing Demand for AEDs in the Market
The mandatory laws and incentivizing of placing automated external defibrillators in easy access public places such as schools, airports, sports arenas, malls, and office buildings, governments surges the demand for this life saving devices in the market. The most critical aspect of the majority of the public access bills targets improving deliverability of AEDs during emergency cases and proper training on effective use for wide diffusion.
For instance, in March 2023, in the United States, a bill was introduced to authorize the Secretary of Health and Human Services to award grants to eligible entities for the development and implementation of a comprehensive program for improving the accessibility of the AEDs in the public elementary schools and secondary schools.
This legislation promotes public safety and creates a bigger market for AED manufacturers due to the compulsion to fit these devices in schools, colleges, institutions and businesses. This regulations further expands the growth of the market as more and more regions enact similar laws and standards that call for more AED devices.
Moreover, the growing public understanding of sudden cardiac arrest and early defibrillation as lifesavers is also pushing governments to stimulate the easy availability of AEDs. This kind of policy enactment encourages innovation and competition, hence pushing the price down and bringing more affordable technology to end-users.
Development of AEDs that can deliver Multiple Aspects of Resuscitation can bring Business Opportunities to the Manufacturer
Traditional automated external defibrillators primarily focuses on defibrillation, inclusion of additional features such as a system that offers CPR feedback, real-time patient monitoring, oxygen delivery, or even advanced analytics for post-event care can make a AED a more holistic and effective resuscitation tool.
Inclusion of this expanded functionalities and capabilities in an AED increases the chances of survival and improve the quality of care which is an utmost priority for every healthcare providers and emergency responder.
This expanded capabilities attracts broader range of healthcare providers and new customer segment such as public health organizations, schools, and corporations looking to meet regulatory requirements or improve their emergency preparedness.
Manufacturers can also market this multiple aspects AEDs as a more advanced and all in one solution that reduces the need of multiple devices and reduces operational cost of an organization.
Moreover, inclusion of these additional features also bring new opportunities to manufacturers of collaborations with healthcare systems, emergency medical services, and even tech companies that can aid them to incorporate data-driven solutions like cloud-based patient monitoring, predictive analytics, and remote device management.
Therefore, the constantly evolving healthcare system towards more patient-centric and connected care models offers a unique opportunities for the AEDs that have expanded resuscitation capabilities.
Increase in Number of Product Recall Hinders the Growth of the Market
Recall of a medical device often occurs when a manufacturer identifies a defect or safety risk in the product. These recalls often create operational challenges for manufacturers, who needs to divert their resources for addressing this issues. This can slow down production and innovation as companies focus on resolving recall-related problems rather than on developing new products or enhancing existing models.
Frequent recalls often lead to negative publicity, causing potential buyers both individuals and organizations to hesitate before investing in AEDs. For instance, in May 2024, Zoll Corporation received recall of their ZOLL Powerheart G5 AED, Semi-Automatic, G5Sxxx Family Automated external defibrillator (AED) which significantly hampered their brand image in the market.
This might make healthcare providers, public facilities, and individuals very cautious while investing or replacing AED units, hence slowing market growth.
Additionally, the costs associated with managing a recall including the logistics of retrieving faulty products, repairing or replacing them, and compensating affected parties-can be financially burdensome for manufacturers, diverting resources away from research, development, and marketing of new models.
Thus, the aggregated effect of frequent recalls often lead to more inclement regulatory environment; greater stringency in the granting of product approvals, with more difficult and complex requirements for manufacturing, which further slow downs the growth of the overall market.
The automated external defibrillator industry recorded a CAGR of 3.7% between 2019 and 2023. According to the industry, Automated External Defibrillator generated USD 1,269.1 million in 2023, up from USD 1,098.2 million in 2019.
An AED is a portable device used in treating sudden cardiac arrest (SCA). These devices are very common in public places, including schools, airports, sports arenas, and workplaces, as well as in healthcare facilities where the operation of emergency medical services, popularly known as EMS, is deployed.
Some of the historical factors that have influenced the growth of the AED market include advances in medical technology, increased awareness of the need for early defibrillation, and changes in health policy supporting public access to life-saving devices.
Government regulatory bodies, like the American Heart Association, have contributed substantially to the implementation of SCA treatment guidelines, which have facilitated the demand for AEDs in public and commercial organizations.
Ongoing trends in the AED market includes the integration of advanced features that enhance the functionality of the device, such as smartphones, real-time data transmission, and more battery life. The growing aging population, increased public awareness of cardiac health, innovative technology, and favorable regulatory environments significantly contributes to the future growth of the market.
Furthermore, amendment of certain policies that encourage further deployment of AEDs in public settings, while improving training programs, create broad-based adoptions on the road which is estimated to contribute to more substantial global growth of the AED market.
Principal Consultant
Companies in the Tier 1 sector account for 65.8% of the global market, ranking them as the dominant players in the industry. Tier 1 players offer a wide range of products compared to other emerging players. These companies have an established industry presence, owing to their continuous innovation.
These factors have significantly aided them to create a substantial influence in the field. Their strong financial resources enables them to enhance their research and development efforts and expand into new markets. Prominent companies within Tier 1 include Zoll Medical Corporation, Koninklijke Philips N.V., Stryker, and NIHON KOHDEN CORPORATION.
Tier 2 players dominate the industry with a 23.2% market share. Tier 2 firms have a strong focus on a specific technologies and a substantial presence in the industry, but they have less influence than Tier 1 firms.
The players are more competitive when it comes to pricing and target niche markets. They constantly focus on introducing new products and services to the growing markets. Tier 2 companies include Shenzhen Mindray Bio-Medical Electronics Co., Ltd., FUKUDA DENSHI and Schiller ag.
Tier 3 companies many of the times are limited to the local markets due to their limited production capabilities and geographical presence. Those in Tier 3 focus primarily on serving a smaller number of clients. Few of the prominent players Metrax GmbH, Avive Solutions, Inc., MEDIANA Co., Ltd.
An analysis of the automated external defibrillator industry is provided in various countries. Several regions throughout the world are examined, including Asia Pacific, North America, and Europe. United States is forecast to remain the leader with a market share of 85.7% in 2023. The market in China is anticipated to grow at a CAGR of 9.4% through 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| United States | 2.5% |
| Canada | 2.8% |
| United Kingdom | 6.0% |
| Germany | 3.7% |
| India | 8.3% |
| China | 8.9% |
| South Korea | 7.9% |
Most of the states in the United States have passed legislation to include AEDs at high-risk areas, such as schools, sports arenas, gyms, and government institutions, thereby helping to increase the survival rate of sudden cardiac arrest (SCA) victims.
These laws create immense demand for AEDs since businesses and institutions are supposed to comply with the requirements because of possible legal liability and assurance of public safety.
This legislative framework encourages the installation of AEDs in public places and increases awareness of their lifesaving potential, thus encouraging more people to use them.
Therefore, the stringent laws enacted by various states in the United States to install AEDs in public places is one of the major factors that is contributing to the growth of the AED market.
These stringent mandates provides incentives and tax benefits to the installer and also aid them to maintain them. Therefore, the stringent regulatory compliance imposed by government of the United States along the growing awareness for sudden cardiac arrest further propels the growth of the AED market in the country.
Older adults are at risk of heart conditions that contribute to the incidences of SCA events; therefore, their access to lifesaving devices like automated external defibrillators increases. The more the number of aged people, the more the cases of cardiovascular diseases and conditions which include sudden cardiac arrest.
With this demographic change, the raising of installation of AEDs at locations with elderly people such as nursing homes, retirement communities, and health centers have become a sturdy call by the health care systems, public facilities, and private institutions. This has also been contributed by the increase in awareness of cardiac health and early defibrillation, which is relatively effectual in bringing up the percentage of survival.
More importantly, the German government and health organizations are laying more emphasis on installing AEDs in public places to save precious time when responding to an emergency, especially in places where the elderly population is higher. The growing health need for aged people in Germany, thus demands an increasing number of AEDs and boosts up the wheel of market growth.
Increased access to automated external defibrillators has been one of the prime drivers of growth in the AED market from the Chinese government. Aged demographics and population in the country tend to raise an increasing incidence of SCA, which stresses the need for increased access to lifesaving AED devices.
The government, for example, installs AEDs in most airports, key railway stations, sports arenas, and major shopping malls that have further access to open space. This is done out of best practice to reduce the occurrence of medical emergencies, shorten emergency response times, and improve survival rates related to cardiac events.
For instance, according to an article published by XINHUANET in January 2021, according to an action plan published in 2019, China has set goal to disseminate AEDs in all schools, government offices, public institutes, airports, shopping malls and cinemas.
Apart from that, the government has supported public education programs regarding the benefits of early defibrillation and has urged companies and institutions to consider installing AEDs as part of health and safety programs.
The fiscal obstacle to acquiring an AED for both public and private establishments was also removed by offering subsidies and other tax advantages upon buying AEDs. These initiatives taken by government in China is anticipating the growth of the AED market in the country.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
A description of the leading segments in the industry is provided in this section. The fully automated external defibrillator segment held 86.1% of the value share in 2023. Based on the end user, public access segment held 80.6% of the market in 2023.
| By Product | Fully Automated External Defibrillator |
|---|---|
| Value Share (2024) | 85.4% |
Several key factors have enabled fully automated external defibrillator (FAEDs) to capture the highest market share in the AED industry such as its ease of use plays the greatest role. Because prior medical training is not needed to operate them, FAEDs perform the analysis of the heart's rhythm automatically and deliver a shock only if required.
This ease of use encourages wide diffusion into public places such as airports, schools, and gyms where incidents may need treatment by non-medical personnel.
These changes in technology have enhanced their accuracy and reliability, hence giving a lot of trust to FAEDs for life-saving interventions. Real-time voice prompts, visual cues, and clear instructions guide to the user during key moments in operation further surges their market growth.
In addition, increasing awareness associated with sudden cardiac arrest (SCA), and the need for immediate action, have further expanded demand for accessible, automated devices.
Moreover, since public health campaigns advocate early defibrillation, Food and Drug Administration authorities have approved and positioned automated external defibrillators as a critical, and easily deployed tools in life saving. These are few of the factors that have aided fully automated external defibrillator segment to hold highest share of the market
| End User | Public Access |
|---|---|
| Value Share (2024) | 80.6% |
Public access defibrillators hold the largest share owing to the growing emphasis of government on reducing rescue times for out-of-hospital SCAs. In effect, public access defibrillators are being installed in high-traffic areas such as airports, shopping malls, schools, and sports venues to ensure that help can be reached in case this device needs to be used.
The increase in awareness of early defibrillation saving lives has remained a major factor in their demand in public spaces. Promotion of programs in bystander interventions and training in CPR and the use of AEDs have bolstered confidence among non-medical personnel in using AEDs effectively.
Besides this, governments, municipalities, and private organizations are enacting legislation for placing AEDs in public places. In addition, growing health consciousness and safety concerns among people make public access AEDs very fundamental to emergency preparedness, which has given another boost to its market share.
Competitor players such as Zoll Medical Corporation, Koninklijke Philips N.V., Stryker, and NIHON KOHDEN CORPORATION holds the majority of the shares of the market as they are known for their wide range of product portfolio and advanced technologies in the market.
Moreover, Strategic partnerships, acquisitions, and global market reach are key strategies that are being adopted by the other key players operating in the market. Growing emphasis of existing players on diversification of their product portfolio further enhances competitiveness. Whereas, improving regulations for public health safety further anticipates the growth of the market in near future.
Recent Industry Developments in the Automated External Defibrillator Market
In terms of product, the industry is segregated into semi-automated external defibrillator and automated external defibrillator
In terms of modality, the industry is segregated into professional use automated external defibrillators and public access automated external defibrillators
In terms of end user, the industry is segmented into healthcare settings (hospitals, clinics, long term care centers, ambulatory surgical centers, emergency medical services (EMS), independent catheterization labs and urgent care centers) and public access (airports, train stations, shopping malls, hypermarket & supermarket, sports arenas/stadiums, schools & colleges, gymnasiums, corporate office buildings, home care settings, parks, hotels & restaurants and others)
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, Middle East, and Africa have been covered in the report.
Automated External Defibrillator are expected to increase at a CAGR of 4.7% between 2024 and 2034.
The fully automated external defibrillator segment is expected to occupy 85.4% market share in 2024.
The market for automated external defibrillator is expected to reach USD 2,097.1 million by 2034.
The United States is forecast to see a CAGR of 2.5% during the assessment period.
The key players in the Automated External Defibrillator industry include Zoll Medical Corporation, Koninklijke Philips N.V., Stryker, NIHON KOHDEN CORPORATION, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., FUKUDA DENSHI, Schiller ag, Metrax GmbH, Avive Solutions, Inc., MEDIANA Co., Ltd., Progetti Medical Equipment Solutions, Bexen, Corpuls, CU Medical Systems, Inc., Promed Technology Co., Limited, INNOMED MEDICAL INC.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. By Product 6.2. By Modality 6.3. By End User 6.4. By Region 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product 7.1. Semi-Automated External Defibrillator 7.2. Fully Automated External Defibrillator 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Modality 8.1. Professional use Automated External Defibrillators 8.2. Public access Automated External Defibrillators 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User 9.1. Healthcare Settings 9.1.1. Hospitals 9.1.2. Clinics 9.1.3. Long Term Care Centers 9.1.4. Ambulatory Surgical Centers 9.1.5. Emergency Medical Services (EMS) 9.1.6. Independent Catheterization Labs 9.1.7. Urgent Care Centers 9.2. Public Access 9.2.1. Airports 9.2.2. Train Stations 9.2.3. Shopping Malls 9.2.4. Hypermarket & Supermarket 9.2.5. Sports Arenas/Stadiums 9.2.6. Schools & Colleges 9.2.7. Gymnasiums 9.2.8. Corporate Office Buildings 9.2.9. Home Care Settings 9.2.10. Parks 9.2.11. Hotels & Restaurants 9.2.12. Others 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. East Asia 10.6. South Asia and Pacific 10.7. Middle East and Africa 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. Sales Forecast 2024 to 2034 by Product, Combination, Modality, Packaging, Distribution Channel for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. Zoll Medical Corporation 20.2. Koninklijke Philips N.V. 20.3. Stryker 20.4. NIHON KOHDEN CORPORATION 20.5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 20.6. FUKUDA DENSHI 20.7. Schiller AG 20.8. Metrax GmbH 20.9. Avive Solutions, Inc. 20.10. MEDIANA CO., Ltd. 20.11. Progetti Medical Equipment Solutions 20.12. Bexen 20.13. Corpuls 20.14. CU Medical Systems, Inc. 20.15. Promed Technology Co., Limited 20.16. INNOMED MEDICAL INC.
Explore Healthcare Insights
View Reports
Automated External Defibrillator Market
